Check out our latest webinar, “Safety and Feasibility of a Compensated Donor Model”. Click here to watch!

Initial Experience of a For-Profit Blood Center Collecting Apheresis Platelets Indicates Feasibility and Safety

Scroll to Top

Federal mandates may constrain platelet availability even more4

The safety of platelet transfusions is critical, and the recent US Food and Drug Administration (FDA) mandate requires bacterial risk mitigation strategies such as large volume delayed sampling or pathogen reduction. Processing requirements associated with these bacterial risk mitigation strategies may further erode the platelet supply.

Secure Transfusion Services Icon